References
- Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11: 269–75.
- Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol 2002; 118: 548–57.
- Robert JM, Macara LM, Chalmers EA, Smith GC. Inter-assay variation in antiphospholipid antibody testing. BJOG 2002; 109: 348–9.
- Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphos-pholipid Forum. Thromb Haemost 2001; 86: 575–83.
- Fontaine M, Homburger HA, Nichols WL. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Thromb Haemost 2001; 86: 1123–4.
- Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999; 31: 142–7.
- Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995; 73: 444–52.
- Coulam CB, McIntyre JA, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet 1990; 335: 865.
- Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphos-pholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–11.
- Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43: 440–3.
- Greaves M, Cohen H, MacHin Si, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704–15.
- Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002; 126: 1424–9.
- Wong RCW, Wilson RJ, Pollock W, Steele RH, Gillis D. Anti-cardiolipin antibody testing and reporting practices among labora-tories participating in a large external Quality Assurance Program. Pathology 2004; 36 in press.
- Ichikawa K, Tsutsumi A, Atsumi T, et al. A chimeric antibody with the human gammal constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum 1999; 42: 2461–70.
- Merrill JT. Which antiphospholipid antibody tests are most useful? Rheum Dis Clin North Am 2001; 27: 525–49.
- Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827–32.
- Wong RCW, Gillis D, Adelstein S, et al. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology 2004; 36 in press.
- Agopian MS, Boctor FN, Peter JB. False-positive test result for IgM anticardiolipin antibody due to IgM rheumatoid factor. Arthritis Rheum 1988; 31: 1212–3.
- Finazzi G. The Italian Registry of Antiphospholipid Antibodies. Haematologica 1997; 82: 101–5.